Close Menu

NEW YORK – Danaher announced Wednesday that it has priced its offering of €1.7 billion ($1.9 billion) senior notes.

The offering consists of €750 million principal amount of 1.7 percent senior notes due 2024; €500 million principal amount of 2.1 percent senior notes due 2026; and €500 million principal amount of 2.5 percent senior notes due 2030.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.